AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM)

CUSIP: 02290A102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
47,920,404
Share change
+10,848,851
Total reported value
$788,769,883
Put/Call ratio
68%
Price per share
$16.46
Number of holders
42
Value change
+$181,589,570
Number of buys
31
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q2 2023

As of 30 Jun 2023, AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,920,404 shares. The largest 10 holders included Darwin Global Management, Ltd., Cormorant Asset Management, LP, D. E. Shaw & Co., Inc., COMMODORE CAPITAL LP, VR Adviser, LLC, FARALLON CAPITAL MANAGEMENT LLC, FMR LLC, Paradigm Biocapital Advisors LP, PRICE T ROWE ASSOCIATES INC /MD/, and Holocene Advisors, LP. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.